Showing results (2491-2500 of 2,695) with videos related to
Sort By:
Pageof 270
The Lancet. Infectious Diseases|May 2, 2022
Haemophagocytic lymphohistiocytosis associated with bartonella peliosis hepatis following kidney transplantation in a patient with HIVDanielle Steed, Jeffrey Collins, Alton B Farris, et al.The Lancet. Infectious Diseases|July 22, 2022
Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trialDan Wu, Chenqi Jin, Khaoula Bessame, et al.The Lancet. Infectious Diseases|April 16, 2022
Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in IndiaInderpaul S Sehgal, Sahajal Dhooria, Valliappan Muthu, et al.The Lancet. Infectious Diseases|January 25, 2016
Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 studyArmand Abergel, Tarik Asselah, Sophie Metivier, et al.The Lancet. Infectious Diseases|January 8, 2016
Mycetoma: a unique neglected tropical diseaseEduard E Zijlstra, Wendy W J van de Sande, Oliverio Welsh, et al.The Lancet. Infectious Diseases|January 8, 2016
Tularaemia: clinical aspects in EuropeMax Maurin, Miklós GyuraneczThe Lancet. Infectious Diseases|February 13, 2016
The transmission of Mycobacterium tuberculosis in high burden settingsTom A Yates, Palwasha Y Khan, Gwenan M Knight, et al.The Lancet. Infectious Diseases|October 4, 2014
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort studyAli S Omrani, Mustafa M Saad, Kamran Baig, et al.The Lancet. Infectious Diseases|October 24, 2015
The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plansJacqueline Deen, Lorenz von Seidlein, Francisco J Luquero, et al.The Lancet. Infectious Diseases|October 9, 2015
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trialAung Pyae Phyo, Podjanee Jittamala, François H Nosten, et al.Pageof 270